Your search for “Multiple System Atrophy” returned 2622 results.
-
Use of NR2D-selective NMDA Receptor Modulators in the Treatment of PD
… disease. Validation that blockade of this receptor system could be beneficial in Parkinson’s disease. Final …
-
Validating Toxic Protein Aggregation as a Therapeutic Target in PD (2)
… These experiments will use two different rodent model systems of PD (rats and mice that overexpress human …
-
Unraveling the genetic basis for alpha-synuclein oligomerization in living cells using bimolecular fluorescence complementation
… cells. Dr. Outeiro and colleagues set out to establish a system in which to visualize these smaller forms, which had …
-
Chronic Directional Deep Brain Stimulation in Parkinson’s Disease
… compare this novel neuromodulation approach with existing systems and will conclude with market clearance for the …
-
Alpha-Synuclein-Expression-Lowering Therapeutics: Initial Pre-Clinical Development
… trials in pre-clinical models. Moreover, by correlating systems pharmacology, gene silencing, endogenous gene and …
-
Identification of ASC as a Disease-modifying Therapeutic Target in Parkinson’s Disease
… complexes that play a central role in the innate immune system, the body’s first line of defense against microbes. …